LYVISPAH 20 mg/1
baclofen · GRANULE · Amneal Pharmaceuticals LLC
No Recall History
Plain English
LYVISPAH is a granule containing baclofen at 20 mg/1, taken oral. Manufactured by Amneal Pharmaceuticals LLC.
Key Facts
- Brand Name
- LYVISPAH
- Generic Name
- baclofen
- NDC Code (Product)
64896-078- Manufacturer
- Amneal Pharmaceuticals LLC
- Strength
- 20 mg/1
- Dosage Form
- GRANULE
- Route
- ORAL
- Marketing Status
- Application #
- NDA215422
- Drug Class
- gamma-Aminobutyric Acid-ergic Agonist [EPC]
- Marketing Start
- 06/01/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is LYVISPAH used for?
LYVISPAH contains baclofen. It is a granule taken oral. Consult your doctor for specific uses.
Is LYVISPAH a controlled substance?
LYVISPAH is not classified as a controlled substance by the DEA.
What is the generic name for LYVISPAH?
The generic name for LYVISPAH is baclofen. There are 12 other brand versions of baclofen.
What is the NDC code for LYVISPAH 20 mg/1?
The NDC (National Drug Code) for LYVISPAH 20 mg/1 is 64896-078, listed by Amneal Pharmaceuticals LLC.